Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, August 2, 2022
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
Suraj Kalia Maintained (TMDX) at Buy with Increased Target to $45 on, Aug 2nd, 2022
Suraj Kalia of Oppenheimer, Maintained "TransMedics Group, Inc." (TMDX) at Buy with Increased Target from $40 to $45 on, Aug 2nd, 2022.
Suraj has made no other calls on TMDX in the last 4 months.
There are 2 other peers that have a rating on TMDX. Out of the 2 peers that are also analyzing TMDX, 1 agrees with Suraj's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Cecilia Furlong of "Morgan Stanley" Maintained at Hold with Increased Target to $34 on, Wednesday, June 29th, 2022
This is the rating of the analyst that currently disagrees with Suraj
- Joshua Jennings of "Cowen & Co." Maintained at Buy with Increased Target to $45 on, Tuesday, July 26th, 2022
